Prestige to gain Insight for US$750 million

28 April 2014 - Deborah Wilkes

Archived

Prestige Brands Holdings is acquiring US OTC company Insight Pharmaceuticals – including the Monistat vaginal antifungal product – for US$750 million in cash.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: